Michael Krebs

8.7k total citations
181 papers, 5.7k citations indexed

About

Michael Krebs is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Michael Krebs has authored 181 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Endocrinology, Diabetes and Metabolism, 49 papers in Surgery and 38 papers in Physiology. Recurrent topics in Michael Krebs's work include Liver Disease Diagnosis and Treatment (23 papers), Bariatric Surgery and Outcomes (21 papers) and Diet and metabolism studies (20 papers). Michael Krebs is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Bariatric Surgery and Outcomes (21 papers) and Diet and metabolism studies (20 papers). Michael Krebs collaborates with scholars based in Austria, Italy and United States. Michael Krebs's co-authors include Michael Roden, Christian Anderwald, P. Nowotny, Martin Bischof, Martin Krššák, Anton Luger, Gerhard Prager, W. Waldhäusl, Elisabeth Bernroider and Erich Roth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Michael Krebs

172 papers receiving 5.6k citations

Peers

Countries citing papers authored by Michael Krebs

Since Specialization

Citations

This map shows the geographic impact of Michael Krebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Krebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Krebs more than expected).

Fields of papers citing papers by Michael Krebs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Krebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Krebs. The network helps show where Michael Krebs may publish in the future.

Co-authorship network of co-authors of Michael Krebs

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Krebs. A scholar is included among the top collaborators of Michael Krebs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Krebs. Michael Krebs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome, a Rare Obesity Syndrome 2025 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), (unknown), Alexandra Kautzky‐Willer, Susanne Greber‐Platzer, Albert Friedrich Stättermayer, Michael Krebs, Thomas Scherer	5
2	Sex differences in ectopic lipid deposits and cardiac function across a wide range of glycemic control: a secondary analysis 2024 ·Obesity ·Jürgen Harreiter, (unknown), Michael Weber, (unknown), (unknown), Yvonne Winhofer, Peter Wolf, Thomas Scherer, Michael Leutner, (unknown), Carola Deischinger, Marek Chmelík, Michael Krebs, Siegfried Trattnig, Martin Krššák, Alexandra Kautzky‐Willer	1
3	The impact of the SARS-CoV2 pandemic on the prescription of thyroid medication in Austria – A nationwide population-based registry analysis 2024 ·Journal of Infection and Public Health ·(unknown), Valentin Ritschl, Berthold Reichardt, Georg Zettinig, Alexandra Kautzky‐Willer, Peter Wolf, Tanja Stamm, Michael Krebs	0
4	International consensus on post-transplantation diabetes mellitus 2024 ·Nephrology Dialysis Transplantation ·Adnan Sharif, Harini A. Chakkera, Aiko P. J. de Vries, Kathrin Eller, Martina Guthoff, Maria Haller, Mads Hornum, (unknown), Alexandra Kautzky‐Willer, Michael Krebs, Aleksandra Kukla, Amelie Kurnikowski, Elisabeth Schwaiger, Núria Montero, Julio Pascual, Trond Jenssen, Esteban Porrini, Manfred Hecking	32
5	Continuous Insulin Therapy to Prevent Post-Transplant Diabetes Mellitus: A Randomized Controlled Trial 2024 ·Kidney Medicine ·Amelie Kurnikowski, Johannes Werzowa, Sebastian Hödlmoser, (unknown), (unknown), (unknown), Andrea Tura, Jürgen Harreiter, Michael Krebs, Peter X.‐K. Song, Kathrin Eller, Julio Pascual, Klemens Budde, Manfred Hecking, Elisabeth Schwaiger	1
6	Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Paul Fellinger, (unknown), Georg Semmler, (unknown), (unknown), (unknown), Martin Gajdošík, Rodrig Marculescu, Greisa Vila, Yvonne Winhofer, Thomas Scherer, Michael Trauner, Alexandra Kautzky‐Willer, Martin Krššák, Michael Krebs, Peter Wolf	7
7	Potential role of skeletal muscle glycerophosphocholine in response to altered fluid balance in humans: an in vivo nuclear magnetic resonance study 2023 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Peter Wolf, (unknown), (unknown), Paul Fellinger, Gregor Heitzinger, (unknown), Michael Leutner, Alexandra Kautzky‐Willer, Martin Krššák, Michael Krebs	1
8	Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial 2022 ·American Journal of Transplantation ·Amelie Kurnikowski, (unknown), Elisabeth Schwaiger, (unknown), Jürgen Harreiter, Alexandra Kautzky‐Willer, Michael Leutner, Johannes Werzowa, Andrea Tura, Klemens Budde, Kathrin Eller, Julio Pascual, Michael Krebs, Trond Jenssen, Manfred Hecking	10
9	Concentration of Gallbladder Phosphatidylcholine in Cholangiopathies: A Phosphorus‐31 Magnetic Resonance Spectroscopy Pilot Study 2021 ·Journal of Magnetic Resonance Imaging ·(unknown), Emina Halilbasic, Martin Gajdošík, (unknown), Marek Chmelík, Thomas Scherer, Siegfried Trattnig, Michael Krebs, Michael Trauner, Martin Krššák	3
10	Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition 2020 ·Diabetes Care ·Peter Wolf, Paul Fellinger, (unknown), (unknown), Patrik Krumpolec, Chiara Barbieri, Amalia Gastaldelli, Jürgen Harreiter, (unknown), Thomas Scherer, Maximilian Zeyda, Sabina Baumgartner‐Parzer, Rodrig Marculescu, Siegfried Trattnig, Alexandra Kautzky‐Willer, Martin Krššák, Michael Krebs	23
11	Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer 2020 ·European Journal of Cancer ·Anna S. Berghoff, (unknown), Angelika M. Starzer, Nicolás Ballarini, Fabian Wolpert, Elisabeth Bergen, Peter Wolf, Ariane Steindl, Georg Widhalm, Brigitte Gatterbauer, Christine Marosi, Karin Dieckmann, Rupert Bartsch, Thomas Scherer, Franz Koenig, Michael Krebs, Michael Weller, Matthias Preusser	12
12	Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly 2020 ·JCI Insight ·Paul Fellinger, Peter Wolf, (unknown), Patrik Krumpolec, Martin Krššák, Kristaps Klavins, Stefan Wolfsberger, Alexander Micko, (unknown), Bettina Gürtl, Greisa Vila, Wolfgang Raber, Clemens Fürnsinn, Thomas Scherer, Siegfried Trattnig, Alexandra Kautzky‐Willer, Michael Krebs, Yvonne Winhofer	23
13	Muscle‐Specific Relation of Acetylcarnitine and Intramyocellular Lipids to Chronic Hyperglycemia: A Pilot 3‐T ¹H MRS Study 2020 ·Obesity ·(unknown), Michael Leutner, (unknown), Michael Krebs, Michael Weber, Siegfried Trattnig, Alexandra Kautzky‐Willer, Martin Krššák	7
14	Antisense Inhibition of Glucagon Receptor by IONIS-GCGRRx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy 2019 ·Diabetes Care ·Erin Morgan, Bruce L. Tai, Nguyen C. Pham, (unknown), Lynnetta M. Watts, (unknown), Shiangtung W. Jung, Martin Gajdošík, Martin Krššák, Michael Krebs, Richard S. Geary, Brenda F. Baker, Sanjay Bhanot	42
15	Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects 2019 ·American Journal of Clinical Nutrition ·(unknown), Martin Gajdošík, (unknown), Stefan Traussnigg, Christian Kienbacher, Emina Halilbasic, (unknown), (unknown), (unknown), Peter Wolf, (unknown), Astrid Hofer, Amalia Gastaldelli, Chiara Barbieri, Anton Luger, Siegfried Trattnig, Alexandra Kautzky‐Willer, Martin Krššák, Michael Trauner, Michael Krebs	25
16	Short-Term Hyperinsulinemia and Hyperglycemia Increase Myocardial Lipid Content in Normal Subjects 2012 ·Diabetes ·Yvonne Winhofer, Martin Krššák, (unknown), Christian Anderwald, Gert Reiter, Astrid Hofer, Siegfried Trattnig, Anton Luger, Michael Krebs	43
17	Long-chain n−3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial 2012 ·American Journal of Clinical Nutrition ·Bianca Itariu, Maximilian Zeyda, Eva Hochbrugger, Angelika Neuhofer, Gerhard Prager, Karin Schindler, Arthur Bohdjalian, Daniel Mascher, (unknown), M. Eric Schranz, Michael Krebs, Martin Bischof, Thomas M. Stulnig	191
18	Blutgasanalyse 2004 ·Der Anaesthesist ·Willehad Boemke, Michael Krebs, Rolf Rossaint	11
19	Massive postoperative intramuscular bleeding in acquired von Willebrand's disease 2002 ·Annals of Hematology ·Michael Krebs, Bernhard M. Meyer, Peter Quehenberger, Peter L. Turecek, Michael Hejna, Wolfgang R. Sperr, Klaus Lechner, Ingrid Pabinger	5
20	Protein C Inhibitor is Expressed in Keratinocytes of Human Skin 1999 ·Journal of Investigative Dermatology ·Michael Krebs, Pavel Uhrín, Anja Vales, (unknown), Johann Wojta, Margarethe Geiger, Bernd R. Binder	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact